Loading clinical trials...
Loading clinical trials...
This study aims to determine the effects of chronic exposure to some low/no calorie sweeteners (LNCS) on glucose tolerance and glucagon like peptide 1 (GLP-1) release in healthy individuals. LNCS exam...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Acibadem University
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT07440147 · Obesity & Overweight, Circadian Rhythm Disorders, and more
NCT07110688 · No Condition, Study Mental State in Healthy Populations and Drug-resistant Epilepsy Patients With Existing iEEG
NCT02969798 · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance (IGT), and more
NCT06964620 · Diabetes Mellitus, Type 2, Impaired Glucose Tolerance
Acıbadem Dr. Şinasi Can (Kadıköy) Hospital
Istanbul, Anadolu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions